Levels of tumor markers CEA/CA 19–9 in serum and peritoneal lavage predict postoperative recurrence in patients with pancreatic cancer
Open Access
- 1 July 2022
- journal article
- research article
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 6 (6) , 862-872
Abstract
Aim: This study aimed to clarify the usefulness of tumor markers from peritoneal lavage in selecting patients with a high risk of recurrence and predicting site‐specific recurrence in patients with pancreatic cancer.Methods: The levels of serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19–9 (sCEA/sCA 19–9) and paired peritoneal lavage CEA and CA 19–9 (pCEA/pCA 19–9) were measured in 90 patients with pancreatic cancer who underwent surgery. Using the cutoff values determined by maximally selected rank statistics for disease‐free survival (DFS), the risk of recurrence and its patterns were evaluated in combination with different markers and different test specimens.Results: In univariate and multivariate analysis, an elevated pCA 19–9 level (>1.3 U/mL) was an independent prognostic marker for both DFS (hazard ratio [HR], 2.391; P = .018) and overall survival (HR, 3.194; P = .033). Combination analyses contributed to further stratification of a very high risk of recurrence. Of the 58 patients with resectable pancreatic cancer who underwent curative resection, elevated pCA19–9 was also associated with inferior DFS and overall survival (OS). Patients with elevated pCA 19–9 levels were more likely to have an earlier onset of peritoneal recurrence than those with normal pCA 19–9 levels (P = .048, Gehan–Breslow–Wilcoxon test).Conclusion: pCA 19–9 is a reliable marker for predicting postoperative recurrence in patients with pancreatic cancer after surgery. Further risk stratification can be achieved by using combination assays. The combination of pCA 19–9 and sCA19–9 also serves as a predictor of recurrence site‐specific recurrence.Keywords
Funding Information
- Nakayama Cancer Research Institute
This publication has 33 references indexed in Scilit:
- Pancreatic Cancer With Malignant AscitesPancreas, 2015
- Reappraisal of Peritoneal Washing Cytology in 984 Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Margin-Negative ResectionJournal of Gastrointestinal Surgery, 2014
- Implications of peritoneal lavage cytology in resectable left-sided pancreatic cancerSurgery Today, 2014
- CEA/CA72-4 levels in peritoneal lavage fluid are predictive factors in patients with gastric carcinomaJournal of Cancer Research and Clinical Oncology, 2014
- Clinical significance of carcinoembryonic antigen in peritoneal lavage from patients with gastric cancerSurgery, 2013
- CEA, AFP and CA 19-9 analysis in peritoneal fluid to differentiate causes of ascites formationClinical Biochemistry, 2013
- CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative TherapyAnnals of Surgical Oncology, 2012
- Presence of minute cancer cell dissemination in peritoneal lavage fluid detected by reverse transcription PCR is an independent prognostic factor in patients with resectable pancreatic cancerSurgery, 2009
- Prognostic Impact of RT-PCR-Based Detection of Peritoneal Micrometastases in Patients with Pancreatic Cancer Undergoing Curative ResectionAnnals of Surgical Oncology, 2009
- Detection of Micrometastases in Peritoneal Washings of Pancreatic Cancer Patients by the Reverse Transcriptase Polymerase Chain ReactionJournal of Gastrointestinal Surgery, 2007